Patents by Inventor Ann Walker

Ann Walker has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20060276516
    Abstract: Compounds of formula (I): are inhibitors of p38 kinase and are useful in the treatment of conditions or disease states mediated by p38 kinase activity or mediated by cytokines produced by the activity of p38.
    Type: Application
    Filed: August 7, 2006
    Publication date: December 7, 2006
    Inventors: Nicola Aston, Paul Bamborough, Ann Walker
  • Publication number: 20060264479
    Abstract: Compounds of formula (I): are inhibitors of p38 kinase and are useful in the treatment of conditions or disease states mediated by p38 kinase activity or mediated by cytokines produced by the activity of p38.
    Type: Application
    Filed: August 7, 2006
    Publication date: November 23, 2006
    Inventors: Nicola Aston, Paul Bamborough, Ann Walker
  • Patent number: 7127395
    Abstract: This invention concerns a method and system for monitoring an automated dialog system for the automatic recognition of language understanding errors based on a user's input communications in a task classification system. The method may include determining whether the user's input communication can be understood in order to make a task classification decision. If the user's input communication cannot be understood and a task classification decision cannot be made, a probability of understanding the user's input communication may be determined. If the probability exceeds a first threshold, further dialog may be conducted with the user. Otherwise, the user may be directed to a human for assistance. In another possible embodiment, the method operates as above except that if the probability exceeds a second threshold, the second threshold being higher than the first, then further dialog may be conducted with the user using the current dialog strategy.
    Type: Grant
    Filed: June 16, 2004
    Date of Patent: October 24, 2006
    Assignee: AT&T Corp.
    Inventors: Allen Louis Gorin, Irene Langkilde Geary, Marilyn Ann Walker, Jeremy H. Wright
  • Publication number: 20060089393
    Abstract: Compounds of formula (I) are inhibitors of p38 kinase and are useful in the treatment of conditions or disease states mediated by p38 kinase activity or mediated by cytokines produced by the activity of p38.
    Type: Application
    Filed: April 29, 2003
    Publication date: April 27, 2006
    Inventors: Richard Angell, Paul Bamborough, Ian Baldwin, Anne-Marie Li-Kwai-Cheung, Timothy Longstaff, Suzanne Merrick, Kathryn Smith, Stephen Swanson, Ann Walker
  • Patent number: 7003459
    Abstract: This invention concerns a method and system for monitoring an automated dialog system for the automatic recognition of language understanding errors based on a user's input communications. The method includes determining whether a probability of understanding the user's input communication exceeds a first thresholds, where if the first threshold is exceeded, further dialog is conducted with the user. Otherwise, the user may be directed to a human for assistance. In another possible embodiment, the method operates as above except that if the probability also exceeds a second threshold, the second threshold being higher than the first, then further dialog is conducted with the user using the current dialog strategy. However, if the probability falls between a first threshold and a second threshold, the dialog strategy may be adapted in order to improve the chances of conducting a successful dialog with the user.
    Type: Grant
    Filed: January 22, 2001
    Date of Patent: February 21, 2006
    Assignee: AT&T Corp.
    Inventors: Allen Louis Gorin, Irene Langkilde Geary, Marilyn Ann Walker, Jeremy H. Wright
  • Patent number: 6941266
    Abstract: The invention concerns a system and method of predicting problematic dialogs in a task classification system based on the user's input communications. The method may include determining whether a task classification decision can be made based on a first automated dialog exchange with the user. As such, if the task classification decision cannot be made, the method may determine whether the probability of conducting a successful automated dialog with the user based on whether the first dialog exchange exceeds a first threshold. The successful dialog may be defined as a dialog exchange between an automated dialog system and the user that results in at least one of processing of the user's input communication and routing the user's input communication. The method may further operate such that if the first threshold is exceeded, further dialog is conducted with the user. Otherwise, the user may be directed to a human for assistance.
    Type: Grant
    Filed: November 15, 2000
    Date of Patent: September 6, 2005
    Assignee: AT&T Corp.
    Inventors: Allen Louis Gorin, Irene Langkilde Geary, Diane Judith Litman, Marilyn Ann Walker, Jeremy H. Wright
  • Publication number: 20050176964
    Abstract: Compounds of formula (I): are inhibitors of p38 kinase and are useful in the treatment of conditions or disease states mediated by p38 kinase activity or mediated by cytokines produced by the activity of p38.
    Type: Application
    Filed: February 10, 2003
    Publication date: August 11, 2005
    Inventors: Nicola Aston, Paul Bamborough, Ann Walker
  • Publication number: 20050090491
    Abstract: Compounds of formula (I) wherein when m is 0 to 4 R1 is selected from C1-6alkyl, C3-7cycloalkyl, C2-6alkenyl, —SO2NR4R5, —CONR4R5 and —COOR4; and when m is 2 to 4 R1 is additionally selected from C1-6alkoxy, hydroxy, NR4R5, —NR4SO2R5, —NR4SOR5, —NR4COR5, and —NR4CONR4R5; R2 is selected from hydrogen, C1-6alkyl and —(CH2)n—C3-7cycloalkyl; R3 is the group R6 is selected from hydrogen and C1-4alkyl; U is selected from methyl and halogen; X and Y are each selected independently from hydrogen, methyl and halogen; m is selected from 0, 1, 2, 3 and 4 wherein each carbon atom of the resulting carbon chain may be optionally substituted with one or two groups selected independently from C1-6alkyl; n is selected from 0, 1, 2 and 3; r is selected from 0, 1 and 2; or pharmaceutically acceptable salts or solvates thereof, and their use as pharmaceuticals, particularly as p38 kinase inhibitors.
    Type: Application
    Filed: October 16, 2002
    Publication date: April 28, 2005
    Inventors: Richard Angell, Paul Bamborough, George Cockerill, Kathryn Smith, Ann Walker
  • Publication number: 20050080257
    Abstract: The present invention relates to a compound of formula (I): corresponding pharmaceutical compositions, preparation processes, and/or methods of using the aforementioned compounds and/or compositions.
    Type: Application
    Filed: February 7, 2002
    Publication date: April 14, 2005
    Inventors: Miles Congreve, Gerard Giblin, Neil Miller, Susan Roomans, Ann Walker, Andrew Mason
  • Publication number: 20050065195
    Abstract: Compounds of formula (I), wherein R3 is the group; or pharmaceutically acceptable salts or solvates thereof, and their use as pharmaceuticals, particularly as p38 kinase inhibitors.
    Type: Application
    Filed: October 16, 2002
    Publication date: March 24, 2005
    Inventors: Richard Angell, Paul Bamborough, George Cockerill, Kathryn Smith, Ann Walker
  • Publication number: 20050038014
    Abstract: Compounds of formula (I): or pharmaceutically acceptable salts or solvates thereof, and their use as pharmaceuticals, particularly as p38 kinase inhibitors.
    Type: Application
    Filed: October 16, 2002
    Publication date: February 17, 2005
    Inventors: Richard Angell, Nicola Aston, Paul Bamborough, Mark Bamford, George Cockerill, Suzanne Merrick, Ann Walker
  • Publication number: 20050020540
    Abstract: Compounds of formula (I): or pharmaceutically acceptable sats or solvates thereof, and their use as pharmaceuticals, particularly as p38 kinase inhibitors.
    Type: Application
    Filed: October 16, 2002
    Publication date: January 27, 2005
    Inventors: Richard Angell, Nicola Aston, Paul Bamborough, Mark Bamford, George Cockerill, Stephen Flack, Dramane Laine, Ann Walker
  • Patent number: 6751591
    Abstract: This invention concerns a method and system for monitoring an automated dialog system for the automatic recognition of language understanding errors based on a user's input communications in a task classification system. The method may include determining whether the user's input communication can be understood in order to make a task classification decision. If the user's input communication cannot be understood and a task classification decision cannot be made, a probability of understanding the user's input communication may be determined. If the probability exceeds a first threshold, further dialog may be conducted with the user. Otherwise, the user may be directed to a human for assistance. In another possible embodiment, the method operates as above except that if the probability exceeds a second threshold, the second threshold being higher than the first, then further dialog may be conducted with the user using the current dialog strategy.
    Type: Grant
    Filed: January 22, 2001
    Date of Patent: June 15, 2004
    Assignee: AT&T Corp.
    Inventors: Allen Louis Gorin, Irene Langkilde Geary, Marilyn Ann Walker, Jeremy H. Wright
  • Patent number: 6127797
    Abstract: This invention provides an improved light-operated telephone that comprises a solar array battery subsidizer or charger and a battery subsidized or charged by the solar array battery subsidizer or charger. The solar array battery subsidizer or charger comprises a solar array, power regulators connected to the solar array, negative and positive battery charging contacts connected to the power regulators, a housing in which the battery charging contacts are positioned and means for transmitting light connecting the solar array to the power regulators and connecting the power regulators to the battery charging contacts. In a preferred embodiment, the improved light-operated telephone has a double-sourced power. The solar rechargeable battery is one source of power (i.e. a primary power source) and is positioned in a primary cell which serves as a solar rechargeable battery compartment and is preferably covered by a crystal plate.
    Type: Grant
    Filed: November 26, 1997
    Date of Patent: October 3, 2000
    Inventor: Mary Ann Walker